Comparison of different biopsy schedules among men on active surveillance: Analysis of the GAP3 global consortium database

by K. Beckmann, C. Bangma, J. Hellman, A. Santa Olalla, D. Nieboer, A. Bjartell, T. Morgan, P. Carroll, B. Trock, R. Valdagni, M. Roobol
Published 2020-07-01

A first step towards a global nomogram to predict disease progression for men on active surveillance

by M. Van Hemelrijck, X. Ji, J. Helleman, M. Roobol, D. Nieboer, C. Bangma, M. Frydenberg, A. Rannikko, L-S. Lee, V. Gnanapragsam, M. Kattan
Published 2020-07-01

Intraoperative NeuroSAFE enables more frequent nerve-sparing radical prostatectomies

by M.A. van der Slot, M.A. Den Bakker, O.S. Klaver, M. Kliffen, M.B. Busstra, J.B.W. Rietbergen, M. Gan, K.E. Hamoen, L.M. Budel, N.T. Goemaere, C.F. Kweldam, C. Bangma, J. Helleman, M.J. Roobol, G.J.L.H. Van Leenders
Published 2020-07-01

PIONEER: European Commission Innovative Medicines Initiative funded BD4BO (Big data for better outcome) project on prostate cancer

by S. Evans Axelsson, T. Abbott, L. Fullwood, M.I. Omar, M. Cavelaars, A. Asiimwe, M. Roobol, M.J. Ribal, C. Auffray, Z. Devecseri, E.J. Smith, M. Van Hemelrijck, S. MacLennan, D. Horgan, C. Reich, B. De Meulder, D. Lancet, C. Bangma, A. Briganti, D. Tilki, H. Van Poppel, M.P. Wirth, J. N’Dow, A. Bjartell
Published 2020-07-01

Factors predicting active treatment free-survival and initial experience with mpMRI as a selection tool in patient undergoing active surveillance: 10-year follow-up of SIUrO PRIAS-...

by M. Roscigno, F. Badenchini, G. Napodano, M. Borghesi, C. Marenghi, T. Magnani, G. Simone, G. Conti, G. Guazzoni, M. Tanello, A. Ranieri, M. Battaglia, A. Lapini, V. Altieri, E. Bollito, G. Cicchetti, P. Colombo, M. Colecchia, P. Ditonno, M. Fabiano, E. Frego, H. Rodolfo, R. Montironi, C. Patriarca, A. Pili, A. Paganelli, R. Sanseverino, T. Rancati, C. Bangma, L.F. Da Pozzo, R. Valdagni
Published 2020-10-01